Rishi Gupta

Insider Reports History

Entity
Individual
Location
C/O Chemocentryx, Inc., 850 Maude Avenue, Mountain View, CA
Signature
/s/ Ben Hohl, by power of attorney
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Rishi Gupta:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Enliven Therapeutics, Inc. Director, 10%+ Owner Common Stock 7.66M $170M $22.14 May 16, 2024 Indirect
Verona Pharma plc Director Ordinary Shares 3.78M $7.46M $1.98 May 15, 2023 Indirect
Turnstone Biologics Corp. Director, 10%+ Owner Common Stock 3.1M Jul 20, 2023 Indirect
Verona Pharma plc Director Share Options (Right to Buy) 96K Apr 28, 2023 Direct
Enliven Therapeutics, Inc. Director, 10%+ Owner Stock Option (right to buy) 20.5K Feb 6, 2025 Direct
Turnstone Biologics Corp. Director, 10%+ Owner Stock Option (Right to Buy) 12.8K Jun 3, 2024 Direct
Turnstone Biologics Corp. Director, 10%+ Owner Series B-1 Preferred Stock 0 Jul 20, 2023 Indirect
Turnstone Biologics Corp. Director, 10%+ Owner Series B-2 Preferred Stock 0 Jul 20, 2023 Indirect
Turnstone Biologics Corp. Director, 10%+ Owner Series C Preferred Stock 0 Jul 20, 2023 Indirect
Turnstone Biologics Corp. Director, 10%+ Owner Series D Preferred Stock 0 Jul 20, 2023 Indirect

Insider Reports Filed by Rishi Gupta

Symbol Company Period Transactions Value $ Form Type Date Filed Role
ELVN Enliven Therapeutics, Inc. Feb 6, 2025 1 $0 4 Feb 10, 2025 Director, 10%+ Owner
TSBX Turnstone Biologics Corp. Jun 3, 2024 1 $0 4 Jul 2, 2024 Director, 10%+ Owner
ELVN Enliven Therapeutics, Inc. May 16, 2024 2 -$22.9M 4 May 20, 2024 Director, 10%+ Owner
ELVN Enliven Therapeutics, Inc. Feb 13, 2024 1 $0 4/A Feb 20, 2024 Director, 10%+ Owner
ELVN Enliven Therapeutics, Inc. Feb 13, 2024 1 $0 4 Feb 15, 2024 Director, 10%+ Owner
TSBX Turnstone Biologics Corp. Oct 16, 2023 1 $0 4 Oct 17, 2023 Director, 10%+ Owner
TSBX Turnstone Biologics Corp. Jul 20, 2023 6 $5M 4 Jul 24, 2023 Director, 10%+ Owner
TSBX Turnstone Biologics Corp. Jul 20, 2023 0 $0 3 Jul 20, 2023 Director, 10%+ Owner
ELVN Enliven Therapeutics, Inc. May 17, 2023 2 $9.1K 4 May 19, 2023 Director, 10%+ Owner
VRNA Verona Pharma plc May 11, 2023 4 -$9.94M 4 May 15, 2023 Director
VRNA Verona Pharma plc Apr 28, 2023 1 $0 4 Apr 28, 2023 Director
ELVN Enliven Therapeutics, Inc. Feb 23, 2023 1 $0 4 Apr 6, 2023 Director, 10%+ Owner
ELVN Enliven Therapeutics, Inc. Feb 23, 2023 2 $0 4 Feb 27, 2023 Director, 10%+ Owner
ELVN Enliven Therapeutics, Inc. Feb 23, 2023 0 $0 3 Feb 27, 2023 Director, 10%+ Owner
VRNA Verona Pharma plc Dec 22, 2022 5 -$136M 4 Dec 27, 2022 Director
VRNA Verona Pharma plc Apr 28, 2022 1 $0 4 Apr 29, 2022 Director
VRNA Verona Pharma plc Aug 9, 2021 1 $0 4 Aug 10, 2021 Director